A detailed history of Venturi Wealth Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Venturi Wealth Management, LLC holds 711 shares of RGEN stock, worth $85,376. This represents 0.01% of its overall portfolio holdings.

Number of Shares
711
Previous 760 6.45%
Holding current value
$85,376
Previous $136,000 4.41%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$170.78 - $208.42 $8,368 - $10,212
-49 Reduced 6.45%
711 $130,000
Q4 2023

Jan 23, 2024

BUY
$114.17 - $185.35 $5,822 - $9,452
51 Added 7.19%
760 $136,000
Q3 2023

Nov 02, 2023

BUY
$138.78 - $176.51 $19,429 - $24,711
140 Added 24.6%
709 $112,000
Q2 2023

Jul 24, 2023

SELL
$138.42 - $180.31 $63,396 - $82,581
-458 Reduced 44.6%
569 $80,000
Q1 2023

May 02, 2023

BUY
$154.26 - $198.1 $158,425 - $203,448
1,027 New
1,027 $172,000
Q3 2019

Oct 29, 2019

BUY
$76.65 - $95.51 $613 - $764
8 New
8 $1,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.66B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Venturi Wealth Management, LLC Portfolio

Follow Venturi Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Venturi Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Venturi Wealth Management, LLC with notifications on news.